PharmiWeb1h
Septoplasty or Rhinoplasty? New Jersey Facial Plastic Surgeon Breaks Down the Difference
Dr. Anni Wong explains functional and aesthetic nasal corrections. FREEHOLD, NEW JERSEY / ACCESSWIRE / January 7, 2025 / In ...
PharmiWeb2h
Adnexus Biotechnologies Inc. Unveils AI-Driven Malaria Cure with Trapicolast
Adnexus Biotechnologies Inc. is at the forefront of the battle against malaria by developing Trapicolast, an antimalarial ...
PharmiWeb3h
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...
PharmiWeb21m
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules
Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indicationsNEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros ...
PharmiWeb21m
Surgical Information Systems (SIS) Earns Tenth Consecutive #1 Client Rating in Ambulatory Surgical Center IT User Satisfaction, Black Book Survey
TAMPA, FLORIDA / ACCESSWIRE / January 7, 2025 / Client experience survey results from 1,914 physicians, clinicians, and administrative staff rate Surgical Information Systems (SIS) first among ...
PharmiWeb49m
Carterra Ships Its First Ultra Biosensor Platform and Finishes 2024 with Double-digit Growth and Record Revenues
Carterra Inc., the world leader in enabling high-throughput biology, announced today that it has sold and shipped its first Carterra Ultra™ biosensor platform. Announced in September 2024, the Ultra ...
PharmiWeb21m
CLS Health Opens New Comprehensive Care Clinic in Cinco Ranch
The 12,000 sq ft multispecialty clinic provides family medicine, specialty care like internal medicine, urology and interventional cardiology, and diagnostic services including lab and imaging, all in ...
PharmiWeb51m
Neuraxpharm to further grow branded business with the acquisition of two leading narcolepsy treatments, Provigil® and Nuvigil®
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces today that it has acquired at the end ...
PharmiWeb53m
4SC announces update relating to Resminostat’s (Kinselby) Marketing Authorisation Application
SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage cutaneous T-cell lymphoma (CTCL), today announced that it had submitted its ...
PharmiWeb48m
Novartis gene therapy poised to expand SMA treatment landscape, says GlobalData
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...
PharmiWeb46m
Evaluate Releases 2025 Preview for Pharma Market
Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.
PharmiWeb1h
Transplantable piezoelectric biomaterial offers new treatment potential for central nervous system injuries and neurodegenerative diseases
A UK research team has created a new material for treating central nervous system injuries and neurodegenerative diseases, offering hope of new therapies to regain lost motor, sensory or cognitive ...